Skip to content
The Policy VaultThe Policy Vault

ZomactonCareFirst (Caremark)

growth hormone deficiency in adults associated with hypothalamic-pituitary disease, congenital structural abnormalities, or childhood-onset GH deficiency

Preferred products

  • Genotropin
  • Humatrope
  • Norditropin
  • Nutropin AQ
  • Omnitrope
  • Saizen

Initial criteria

  • Member meets ANY of the following criteria:
  • Current IGF-1 level is not elevated for age and gender
  • Member has organic hypothalamic-pituitary disease (e.g., suprasellar mass with previous surgery and cranial irradiation) with ≥ 3 documented pituitary hormone deficiencies
  • Member has genetic or congenital structural hypothalamic-pituitary defects
  • Member has childhood-onset GH deficiency and a congenital abnormality of the CNS, hypothalamus, or pituitary